What The Financials Tell Us About Sabra Health Care REIT Inc. (SBRA)

0
12
KOSK Stock
KOSK Stock

Sabra Health Care REIT Inc. (NASDAQ:SBRA) finished Thursday with a subtraction of -$0.38 to close at $13.24, a downside of -2.79 percent. An average of 1,365,618 shares of common stock have been traded in the last five days. There was a fall of -$0.72 in the past week, and it reached a new high 9 times over the past 12 months. The last 20 days have seen an average of 2,076,209 shares traded, while the 50-day average volume stands at 1,767,234.

SBRA stock has decreased by -12.58% in the last month. The company shares reached their 1-month lowest point of $13.19 on 09/23/22. With the stock rallying to its 52-week high on 08/15/22, shares of the company touched a low of $11.44 and a high of $16.60 in 52 weeks. It has reached a new high 17 times so far this year and achieved 0.59% or -$0.34 in price. In spite of this, the price is down -20.24% from the 52-week high.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored


Insider Transactions

268 days have passed since Sabra Health Care REIT Inc. (SBRA) last reported insider trading activity. Andrews Harold W. Jr., who is Executive VP, CFO & Secretary, most recently acquired $110,000 shares at $13.55 per share on Dec 29.

Valuation Metrics

Sabra Health Care REIT Inc. (SBRA) has a trailing price-to-earnings (P/E) ratio of 72.83. The stock’s beta is 1.32. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 5.27, the price-to-book (PB) ratio at 0.95, and the price-to-cash flow ratio at 245.70.

The company has a payout ratio of 638.50%. The company’s most recent quarterly dividend payment was $0.30 a share, without any change from last year. Its latest decrease dividend $0.15 reported on Wednesday May 6 2020.

Financial Health

Further, the company has a long term debt to equity ratio of 0.75 and a total debt to equity ratio of 0.75 for the quarter ending June 29. Its gross profit as reported stood at $201.25 million compared to revenue of $569.54 million.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Sabra Health Care REIT Inc.’s return on assets was 0.70%.

Earnings Surprise

For the three-month period that ended June 29, Sabra Health Care REIT Inc. had $50.18 million in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $16.81 million in the quarter, while revenues were grew 888.64%. The analyst consensus anticipated Sabra Health Care REIT Inc.’s latest quarter earnings to come in at $0.16 per share, but it turned out to be $0.07, a -56.20% surprise. For the quarter, EBITDA amounted to $96.95 million. At the end of the quarter ending June 29, Sabra Health Care REIT Inc.’s stock balance sheet showed total debt was $2.48 billion. Shareholders own equity worth $230.97 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Sabra Health Care REIT Inc. (SBRA) price momentum. RSI 9-day as of the close on 22 September was 24.63%, suggesting the stock is oversold, with historical volatility in this time frame at 33.15%.

As of today, SBRA’s price is $13.77 -5.14% or -$0.72 from its 5-day moving average. SBRA is currently trading -15.62% lower than its 20-day SMA and +13.45% higher than its 100-day SMA. However, the stock’s current price level is -7.14% below the SMA50 and -2.76% below the SMA200.

The stochastic %K and %D were 14.25% and 24.20%, respectively, and the average true range (ATR) was 0.43. With the 14-day stochastic at 0.75% and the average true range at 0.41, the RSI (14) stands at 29.03%. The stock has reached -0.29 on the 9-day MACD Oscillator while the 14-day reading was at -0.62.

Analyst Ratings

Jefferies downgraded Sabra Health Care REIT Inc. (NASDAQ: SBRA) to a a Hold rating in its most recent analyst report. Previously, the stock was rated as a Buy. The consensus rating for Sabra Health Care REIT Inc. (SBRA) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell SBRA, while 8 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 1 analysts, while 6 others rate it as a “buy”.

What is SBRA’s price target for the next 12 months?

Analysts predict a range of price targets between $14.00 and $20.00, with a median target of $16.00. Taking a look at these predictions, the average price target given by analysts for Sabra Health Care REIT Inc. (SBRA) stock is $16.34.

LEAVE A REPLY

Please enter your comment!
Please enter your name here